Clexio Biosciences

Drug Therapies for Treatment of Neurological Conditions

Health Tech & Life Sciences
Active
Pre-Funding Petah Tikva, Israel Founded 2018
Website ↗ LinkedIn
Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2018
Headcount
43
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences

About

Clexio Biosciences is a clinical-stage pharmaceutical company developing CNS therapies designed to address patients unmet needs through a scientifically based fusion of drugs and innovative technologies. Clexios growing pipeline is focused on the development of safe and effective treatments with rapid onset of action for a wide range of neurological and psychiatric conditions, including major depressive disorder, Parkinsons disease, pain, and other conditions involving impairment of the neurological system.

Q&A

What is Clexio Biosciences' primary focus?
Clexio Biosciences is a clinical-stage pharmaceutical company developing CNS therapies for neurological and psychiatric conditions, including major depressive disorder, Parkinson's disease, and pain.
When was Clexio Biosciences founded?
Clexio Biosciences was founded in March 2018.
Where is Clexio Biosciences headquartered?
Clexio Biosciences is headquartered in Petah Tikva, Israel.
What is the current employee count for Clexio Biosciences?
Clexio Biosciences has 11-50 employees.
Who are the co-founders of Clexio Biosciences?
The co-founders of Clexio Biosciences are Elisabeth Kogan (Co-founder & CEO) and Menashe Levy (Co-founder & CTO).
What is Clexio Biosciences' current funding stage?
Clexio Biosciences is currently in the Pre-Funding stage.
What sector does Clexio Biosciences primarily operate in?
Clexio Biosciences primarily operates in the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
What is the product stage of Clexio Biosciences' offerings?
Clexio Biosciences' products are in the clinical trial stage.

Team · 2

Elisabeth Kogan
Founder · Co-founder & CEO
LinkedIn ↗
Menashe Levy
Founder · Co-founder & CTO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

Verified

Tags

pharmaceuticalstherapeuticsparkinsonpatientspain-reliefmental-healthcns-disordersdrug-discoverytreatmentsbioconvergence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)